For the first time in history, new drugs could prove to be the game changer to stem the tide of people living with obesity, an epidemic which has grown exponentially since the 1970s, costing $173 billion per year in medical costs in the United States alone
Benefits of Semaglutide and Tirzepitide Non-stimulant therefor safe for patients with cardiovascular disease Non addictive, not a controlled substance Reduces appetite and food cravings while increasing sensation of fullness Lowers weight, waist size, blood pressure, blood sugar and inflammation Most patients had a 15% weight loss with many losing more than 20% Painless weekly injection with a tiny needle injected into belly fat You are not a candidate for semaglutide if you had any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, medullary thyroid cancer or a family history of medullary thyroid cancer or multiple endocrine neoplasia type 2
Please avoid exercise, caffeine and alcohol for 24 hours after each IM Vitamin B12 shot
B vitamins, cognition, and aging: a review